NCT05308732 2026-01-08
Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy
Instituto Nacional de Cancer, Brazil
Phase 1 Active not recruiting
Instituto Nacional de Cancer, Brazil
Tata Memorial Hospital
Turku University Hospital
EDDC (Experimental Drug Development Centre), A*STAR Research Entities
Austin Health